Back to Agendas
[V4-S5] CRO Outsourcing Model – History and Future Outlook – Sponsor’s & CRO’s Perspective
Session Chair(s)
Shogo Nakamori, MBA, MSc, RPh
Senior Vice President & Managing Director, DIA Japan, Korea, and Singapore, DIA, Japan
CRO outsourcing started with so-called “functional outsourcing,” where only a few functions, such as monitoring or data management, are outsourced. In the past short five years, various types of outsourcing models have been developed in order to pursue higher productivity, including a “full service model,” where almost all functions are outsourced to cover clinical trial implementation from the very beginning to the end, or the “partnership model,” where the sponsor identifies a limited number of CROs and outsourced their entire clinical work by building a strategic alliance. Such outsourcing models vary depending on the sponsors, but there have not been many opportunities to evaluate and discuss various outsourcing models based on the experience. In this session, we invite speakers from both sponsors and CROs, and provide opportunity to compare and evaluate various outsourcing models and discuss how we should envision the future of such business models.
Speaker(s)
Yoshihisa Narita
Senior Director, Global Clinical Development, PPD-SNBL K.K., Japan
CRO Outsourcing Model (History and Future outlook) - From foreign companies' points of views -
Kaoru Tsuda
Director, Japan Asia Clinical Development Administration, Astellas Pharma Inc., Japan
Future CRO Outsourcing Model - Best Partnership -
Shoji Yamada
Director, Division Manager, Clinical Development Division, A2 Healthcare Corporation, Japan
CRO Outsourcing Model – History and Future Outlook – CRO’s Perspective 1
Tomoaki Miyazawa, PhD, MBA
Senior Client Relationship Director, PAREXEL International Inc., Japan
CRO Outsourcing Model – History and Future Outlook – CRO’s Perspective 2
Have an account?